2026 ICD-10-CM Diagnosis Code C01Malignant neoplasm of base of tongue

ICD-10-CM CodesC00–D49C00-C14C01

ICD-10-CM C01
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C01 is a billable ICD-10-CM diagnosis code for malignant neoplasm of base of tongue. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 11 through 13, 146 through 148. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Head and neck cancers - lip and oral cavity.

For Medicare Advantage risk adjustment, C01 maps to CMS-HCC Category 21 (Lymphoma and Other Cancers) under the V28 model, adding a risk factor of about 0.671 for a community, non-dual, aged beneficiary in payment year 2026.

Code Identity

ICD-10-CM Code
C01
Billable Status
Yes — Valid for Submission
Code Describes
Malignant neoplasm of base of tongue
Short Description
Malignant neoplasm of base of tongue
Same as the full description in the CMS dataset.
Chapter
C00-C14
Malignant neoplasms of lip, oral cavity and pharynx

Code Classification

ChapterC00–D49Neoplasms
SectionC00-C14Malignant neoplasms of lip, oral cavity and pharynx
CategoryC01Malignant neoplasm of base of tongue
This CodeC01Malignant neoplasm of base of tongue

Medicare Risk Adjustment (HCC)Billing

C01 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.

CMS-HCC V28 Category (Payment Model)
HCC 21— Lymphoma and Other Cancers
Payment HCC · PY 2026 one of 463 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.671
community, non-dual, aged · ranges 0.493–0.739 across segments
Hierarchy
Superseded by HCC 17, HCC 18, HCC 19, and HCC 20
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 11
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 11 · ESRD (V21): HCC 11 · ESRD (V24): HCC 11
ESRD V21 weights: 0.076 dialysis, 0.284–0.298 functioning graft · ESRD V24 weights: 0.059 dialysis, 0.257–0.362 functioning graft
Part D (RxHCC)
RxHCC 22 — Prostate, Breast, Bladder, and Other Cancers and Tumors
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Carcinoma of base of tongue
  • Carcinoma of tongue base - dorsal surface
  • Malignant neoplasm of base of tongue
  • Malignant neoplasm of base of tongue dorsal surface
  • Primary carcinoma of base of tongue
  • Primary carcinoma of tongue base - dorsal surface
  • Primary malignant neoplasm of base of tongue
  • Primary malignant neoplasm of dorsal surface of tongue
  • Primary squamous cell carcinoma of base of tongue
  • Primary tongue carcinoma

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Malignant neoplasm of dorsal surface of base of tongue
  • Malignant neoplasm of fixed part of tongue NOS
  • Malignant neoplasm of posterior third of tongue

Use Additional Code

  • code to identify:
  • alcohol abuse and dependence F10
  • history of tobacco dependence Z87.891
  • tobacco dependence F17
  • tobacco use Z72.0

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO002
Head and neck cancers - lip and oral cavity
Default principal diagnosis: inpatient Yes · outpatient Yes

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
tongue base (dorsal surface)C01C79.89D00.07D10.1D37.02D49.0
tongue fixed part NECC01C79.89D00.07D10.1D37.02D49.0
tongue posterior (third)C01C79.89D00.07D10.1D37.02D49.0
tongue rootC01C79.89D00.07D10.1D37.02D49.0
tongue surface (dorsal) baseC01C79.89D00.07D10.1D37.02D49.0

Patient EducationClinical

Oral Cancer

Oral cancer is cancer of the mouth. It is a type of head and neck cancer. Most oral cancers are squamous cell cancers. They begin in the flat cells that cover the surfaces of your mouth, tongue, and lips. The cancer cells may spread into deeper tissue as the cancer grows.

The full article covers:

  • What is oral cancer?
  • Who is more likely to develop oral cancer?
  • What are the symptoms of oral cancer?
  • How is oral cancer diagnosed?
  • What are the treatments for oral cancer?
  • Can oral cancer be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C01 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
141.0 Mal neo tongue base
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C01Overview

What is the ICD-10 code for malignant neoplasm of base of tongue?

The ICD-10-CM code for malignant neoplasm of base of tongue is C01. It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is C01 (Malignant neoplasm of base of tongue) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of base of tongue on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C01 group to?

When malignant neoplasm of base of tongue is the principal diagnosis on an inpatient stay, it groups to MS-DRG 11, 12, 13, 146, 147, 148, with relative weights from 0.7971 to 5.4541 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of C01?

Under the General Equivalence Mappings, malignant neoplasm of base of tongue converts to ICD-9-CM 141.0 (mal neo tongue base). The mapping is a direct match.

What HCC is C01?

C01 (malignant neoplasm of base of tongue) maps to CMS-HCC Category 21 (Lymphoma and Other Cancers), commonly written as HCC 21, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 11 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 22.

Does C01 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, C01 adds a risk adjustment factor of about 0.671 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.493 to 0.739 depending on the payment segment). A more severe related category (HCC 17, HCC 18, HCC 19, and HCC 20) supersedes it when both are reported. See the full factor table on the HCC 21 category page.